US Patent Issued to The University of Chicago on Nov. 11 for "Methods and compositions for treating inflammatory and autoimmune conditions with ECM-affinity peptides linked to anti-inflammatory agents" (Illinois Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,640, issued on Nov. 11, was assigned to The University of Chicago (Chicago).

"Methods and compositions for treating inflammatory and autoimmune conditions with ECM-affinity peptides linked to anti-inflammatory agents" was invented by Jeffrey A. Hubbell (Chicago), Kiyomitsu Katsumata (Chicago), Ako Ishihara (Chicago), Jun Ishihara (Chicago) and Aslan Mansurov (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the engineering of collagen-binding modification of anti-inflammatory agents using collagen-binding peptide (CBP) and vWF A3 to achieve targeted therapy for inflammatory diseases. Accordingly, embodiments of the di...